Skip to main content
Smart Investors Daily
Balchem Corporation logo

NASDAQ · BCPC

Balchem Corporation

Basic Materials · Chemicals - Specialty

$169.98

Down-$0.42 (-0.25%)

Updated Nov 1, 2026, 2:17 AM

SID Score

5.5/10

Composite research score

Smart Money

59/100

Neutral

Market cap
5.09B
P/E ratio
34.44
Dividend yield
0.51%
52-week range
$147.18 – $183.90
Volume
249.29K
Avg. volume
172.4K

Price performance · BCPC

BCPC price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 30, 2026

BCPC closed at $169.98 after 20 trading sessions, up 2.37% for the selected period.

Last close
$169.98
Period change
+2.37%
Period low
$165.29
Period high
$177.00
Daily close
View OHLC price history
BCPC OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 30, 2026$172.89$172.89$169.73$169.98249.29K
Oct 29, 2026$168.32$170.62$166.5301$170.40196.2K
Oct 28, 2026$169.52$170.40$165.77$166.30168.34K
Oct 27, 2026$170.24$170.81$168.20$168.70224.75K
Oct 26, 2026$178.12$178.57$169.64$170.62331.09K
Oct 23, 2026$175.83$177.45$173.085$177.00717.79K
Oct 22, 2026$170.68$173.43$170.54$173.23493.94K
Oct 21, 2026$171.11$172.74$170.25$170.78452.86K
Oct 20, 2026$170.68$172.585$169.7152$171.62336.34K
Oct 19, 2026$170.61$171.11$169.98$170.42363.5K
Oct 16, 2026$171.16$172.39$169.95$170.73197.3K
Oct 15, 2026$172.06$174.29$170.31$170.53349.11K
Oct 14, 2026$169.40$170.525$168.02$170.46250.06K
Oct 13, 2026$168.50$171.04$167.02$169.72240.02K
Oct 12, 2026$167.64$168.9375$166.145$168.19175.41K
Oct 9, 2026$169.50$171.06$167.565$167.83334.83K
Oct 8, 2026$166.65$169.63$164.56$168.63211.02K
Oct 7, 2026$164.12$167.53$164.12$166.41480.2K
Oct 6, 2026$167.18$167.91$164.585$165.29165.89K
Oct 5, 2026$166.03$167.715$164.93$166.04272.22K

Latest BCPC news

The latest Smart Investors Daily articles mentioning BCPC.

BCPC research

Overview

Company profile and research snapshot.

Company profile

Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$175.50
Implied upside
—
Analysts
—
BCPC recent ratings
DateFirmRatingTarget
Aug 3, 2026HC Wainwright & Co.Buy—
May 4, 2026HC Wainwright & Co.Buy—
Feb 24, 2026HC Wainwright & Co.Buy—
Dec 5, 2025Rothschild & CoNeutral—
Oct 22, 2025HC Wainwright & Co.Buy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 25, 2026

Balchem (BCPC) Stock Can Q3 Earnings Spark A Bigger Rerating?

The Q3 2026 release from Balchem landed with a clean headline. Record quarterly revenue of about US$291 million and adjusted earnings per share of US$1.57, both tied to stronger profitability, gave the report real substance. Yet the stock only moved about 2% higher on the day, a polite nod rather than a cheer. For an ingredients specialist that lives and dies on margin quality, that muted reaction sets up a clear question for investors: Is the market underplaying how much this quarter says...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.